Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Covington
AstraZeneca
US Army
Mallinckrodt
Deloitte
Medtronic
Fuji
Argus Health
Citi

Generated: August 16, 2017

DrugPatentWatch Database Preview

AUVI-Q Drug Profile

« Back to Dashboard

Which patents cover Auvi-q, and what generic Auvi-q alternatives are available?

Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. There are twenty-one patents protecting this drug.

This drug has ninety-nine patent family members in fourteen countries.

The generic ingredient in AUVI-Q is epinephrine. There are nineteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

Summary for Tradename: AUVI-Q

Patents:21
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list54
Patent Applications: see list8,164
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AUVI-Q at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY ► Subscribe
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY ► Subscribe
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY ► Subscribe
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY ► Subscribe
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: AUVI-Q

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,172,082Devices, systems and methods for medicament delivery► Subscribe
9,278,177Medical injector with compliance tracking and monitoring► Subscribe
7,416,540Devices systems and methods for medicament delivery► Subscribe
9,022,980Medical injector simulation device► Subscribe
8,361,026Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: AUVI-Q

Country Document Number Estimated Expiration
Mexico2007009152► Subscribe
World Intellectual Property Organization (WIPO)2010056712► Subscribe
New Zealand555256► Subscribe
World Intellectual Property Organization (WIPO)2008081446► Subscribe
United Kingdom201114400► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Healthtrust
US Army
US Department of Justice
Cerilliant
Cipla
Daiichi Sankyo
Fish and Richardson
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot